Colin Hislop

Colin Hislop is a declared insider at 2 companies; the most frequent names are Anthera Pharmaceuticals Inc and Aravive, Inc. Over a trading history stretching from 30 June 2010 to 19 October 2017, the count stands at 26 filings.

On the open market, the record shows 3 purchases worth €1,867 and 6 sales worth €1.0M. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 10 share grants and 7 option exercises. So far in 2017, the count stands at no purchases and 2 sales.

Most recently, on 23 October 2017, the filings show an open-market sale worth €1,436 in Aravive, Inc. The clock since the last published purchase (14 February 2011) now reads 5,730 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.